The firms behind WEN hair-care products – linked to mass reports of hair loss and other adverse events – could put the bulk of litigation and associated payouts in their rearview in 2017, but FDA’s investigation into the issue continues, with potential implications for cosmetics reform legislation in the 115th Congress.
An official WEN class-action settlement website is up now, inviting claims from class members through April 28, 2017....



